Algeria – The Embassy of the United States of America (USA) in Algeria congratulates Algerian scientist Dr. Salim Bouguermouh, who is collaborating in the development of the anti-Covid-19 vaccine at the American company Pfizer.
Indeed, this afternoon a message appeared, in Arabic and in English from the American Embassy in Algeria congratulating the Algerian scientist, Salim Bouguermouh, for his remarkable work with the company Pfizer which is continuing the process of developing its vaccine. against Covid-19.
“Congratulations to Algerian researcher Dr Salim Bouguermouh, who is part of the team that developed a candidate vaccine against Covid-19”. This is what the diplomatic representation wrote on its Facebook page on November 14. This vaccine “uses a technique known as mRNA,” adds the same source.
A little further on, the Embassy writes a brief biographical overview of the honored specialist. Thus, she specifies that โDr Bouguermouh is deputy director of research in vaccine development. He holds this position at “US pharmaceutical company Pfizer”.
The exceptional career of Salim Bouguermouh, a native of Bรฉjaรฏa
Indeed, Salim Bouguermouh who was born in Ifri-Ouzellaguen in the wilaya of Bรฉjaรฏa in Kabylia has several diplomas to his credit. Incidentally, the scientist said that initially he struggled to find work. He was told he was over-educated.
It was he himself who reported this episode in his life. Something he had done during a speech at a panel discussion. This dates back a few years. The American diplomatic representation in Algiers also recalls the obtaining of his medical degree. He had therefore “obtained […] from the University of Algiers in 1996”.
This โbefore doing postdoctoral research at Harvard Medical School later. On November 9, Pfizer and its German partner BioNTech announced that the third phase of the vaccine was effective โ. Efficacy rate exceeded, “90% to prevent infection with Covid-19”, same source said.
https://www.facebook.com/USEmbassyAlgiers/posts/3666298853391382